UBS raises Adient stock price target to $26 on solid performance

Published 07/08/2025, 11:46
UBS raises Adient stock price target to $26 on solid performance

Investing.com - UBS raised its price target on Adient (NYSE:ADNT) to $26.00 from $25.00 on Thursday, while maintaining a Neutral rating on the automotive seating supplier. According to InvestingPro data, the stock has shown strong momentum with a 35.5% return over the past six months, trading at an EV/EBITDA multiple of 4.9x.

The investment bank cited Adient’s continued solid business performance as one factor strengthening the company’s investment thesis. UBS also noted that Adient stands to benefit from manufacturing reshoring to the United States.

UBS analyst Joseph Spak highlighted a path to normalized free cash flow in the $300-400 million range for Adient. Despite these positive factors, the bank maintained its Neutral stance on the stock.

The analyst noted that while these benefits are becoming clearer, they will take time to materialize. In the interim, restructuring costs could remain elevated, potentially reducing free cash flow potential.

UBS’s revised price target reflects a modest 1.5% increase to its forecast, with the bank’s FY26 EBITDA estimate sitting approximately 3.5% above consensus expectations.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.